Evidence map›Paper›PMID 33376308›Full record

ArticleDrug design, development and therapy2020

Preventive Effect of

Tiantian Hu, Hongxia Wang, Chengzheng Xiang, Jianfei Mu, Xin Zhao

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluating the Therapeutic Efficacy ofCurrent pharmaceutical design · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Dietary Supplementation of Haskap Berry (Foods (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Frontiers in microbiology · 2023
    Article
  15. Different Effects of DifferentInternational journal of molecular sciences · 2022
    Article
  16. Article
  17. Review
  18. Frontiers in nutrition · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tiantian Hu *Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, People's Republic of China.ORCID 0000-0003-0195-1556
Hongxia Wang *Department of Paediatrics, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine (Haikou People's Hospital), Haikou, Hainan, People's Republic of China.
Chengzheng XiangChongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, People's Republic of China.
Jianfei MuChongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, People's Republic of China.
Xin ZhaoChongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, People's Republic of China.ORCID 0000-0001-9798-7865
Chongqing University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLactobacillus acidophilus is widely used as probiotic supplement in functional foods due to its beneficial regulatory effects on host, such as immune regulation, anti-inflammatory, and antioxidant activities.

aimThis study aimed to determine the preventive effect of

methodsThe mice were randomly divided into five groups. Except for the control group, the other four groups were induced for ulcerative colitis (UC) with dextran sodium sulfate (DSS), and three groups in DSS-groups were treated with

resultsThe results showed that the mice in the

conclusionThe results of the experiment suggested that

Indexed as

AnimalsAntioxidantsColitis, UlcerativeDextran SulfateLactobacillus acidophilusMaleMiceMice, Inbred C57BLProbioticsAntioxidantsDextran Sulfatedextran sodium sulfateLactobacillus acidophilus XY27Lactobacillus bulgaricusulcerative colitis

Identifiers

PMID33376308
PMCPMC7764796
OpenAlexW3115843163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.